Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.11 USD | +1.26% | +8.41% | -11.43% |
07/05 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
07/05 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.43% | 190.25Cr | |
+29.77% | 4.95TCr | |
+1.00% | 4.26TCr | |
+50.47% | 4.25TCr | |
-5.26% | 2.91TCr | |
+13.68% | 2.66TCr | |
-22.99% | 1.86TCr | |
+8.22% | 1.32TCr | |
+32.41% | 1.25TCr | |
-1.62% | 1.2TCr |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- Barclays Adjusts Price Target on Beam Therapeutics to $41 From $45, Keeps Equalweight Rating